SCHEMBL8917922

SCHEMBL8917922

CC[C@H](C)CCCCCCOc1cnc(-c2cc[c]cc2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.40
KDM4E B2RXH2 6/20 0.40
NPC1 O15118 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPT P10636 4/20 0.36
RARB P10826 4/20 0.34
ALDH1A1 P00352 5/20 0.32
HPGD P15428 4/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
HTT P42858 1/20 0.32
NAAA Q02083 1/20 0.32
KMT2A Q03164 2/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
GAA P10253 1/20 0.30
CYP19A1 P11511 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8917930 1.00 RAB9A (0.40) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL9239218 0.85 NPC1 (0.57) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL9232965 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL10467929 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL10468279 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL9236065 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL9240109 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL9239947 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL10468405 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL10469343 0.84 NPC1 (0.56) RAB9AKDM4ENPC1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5651918-A Optically active 1,3-dioxolane derivatives carrying a mesogenic radical in the 4-position, a process for their preparation and their use as doping agents in liquid-crystal mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1997-07-29 US disclosed